Title: An Update on the Pharmaceutical Management of Glaucoma
October 14, 2020
8:00 pm ET
After registering, you will receive a confirmation email containing information about joining the webinar.
Language: English only
Through this 60-minute webinar, Dr. Harasymowycz will provide a detailed presentation of existing and new drugs for treating glaucoma and best practices for clinical assessment with case-based examples. There will be time for a Q&A period between the participants and Dr. Harasymowycz.
At the end of this webinar, participants will be able to:
- Evaluate data demonstrating the value of low target pressures in glaucoma treatment
- Review other risk factors for glaucomatous progression despite ‘adequate’ IOP control
- Describe new treatment modalities currently available or on the horizon for non-surgical glaucoma treatment
Dr. Paul Harasymowyzc, Dr. Jeff Martow and Dr. Karin Oliver
This webinar is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada and approved by the Canadian Ophthalmological Society You may claim a maximum of 1 hours.
This webinar was co-developed with COS and Aequus Pharmaceuticals and was planned to achieve scientific integrity, objectivity and balance.